2-[18F]-fluoro-2-deoxy-d-glucose (FDG) is the radiopharmaceutical most frequently used for
clinical positron emission tomography (PET). However, FDG cannot be used for many …

Fluorine-18 (18F, β+; 96.7%, T1/2= 109.8 min) is of considerable importance for developing
positron emission tomography (PET) ligands for imaging receptor, enzyme, gene expression …

18F-2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl) nortropane (18F-FECNT), a
PET radioligand for the dopamine transporter (DAT), generates a radiometabolite that enters …

Abstract Purpose Diagnosing Parkinson's disease (PD) on clinical grounds may be difficult,
especially in the early stages of the disease. F-DOPA PET and FP-CIT SPECT scans are …

Abstract Purpose Diagnosis of Parkinson's disease (PD) can be difficult. F-DOPA PET is
able to quantify striatal dopa decarboxylase activity and storage capacity of F-dopamine, but …

Fluorine-18 labeled 2β-carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl) nortropane
(FECNT) was synthesized in the development of a dopamine transporter (DAT) imaging …

The aim of this study was to do an initial assessment of the usefulness of 2β-carbomethoxy-
3β-(4-chlorophenyl)-8-(2-18F-fluoroethyl) nortropane (18F-FECNT) PET scanning in …

Although [18F] fluoropropylcarbomethoxyiodophenylnortro… (FP-CIT) is a promising
radiopharmaceutical for dopamine transporter imaging, it has not been used for clinical …

In the study of Timmers et al.(1) published in this issue of The Journal of Nuclear Medicine,
11 patients with pheochromocytoma and extraadrenal abdominal paraganglioma were …

Purpose We aimed to determine the composition of radioactivity in rat brain after intravenous
administration of the dopamine transporter radioligand,[11 C] PE2I. Methods PET time …